Component information
Different name of ingredient
- Uniprost
- LRX 15 (United Therapeutics, USA)
- U 62840 (United Therapeutics, USA)
- 15 AU 81 (United Therapeutics, USA)
- (1R,2R,3aS,9aS)-2-[2-Hydroxy-1-[(S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-benzy[f]inden-5-yloxy]essigsäure
- Treprostinol
- Treprostinilum
- Treprostinilo
- [[(1R,2R,3aS,9aS)-2-Hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphthalen-5-yl]oxy]acetic acid
- Acide [[(1R,2R,3aS,9aS)-2-hydroxy-1-[3-(S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphthalen-5-yl]oxy]acetique
- Acido [[(1R,2R,3aS,9aS)-2-hidroxi-1-[3-(S)-3-hidroxioctil]-2,3,3a,4,9,9a-hexahidro-1H-ciclopenta[b]naftalen-5-il]oxi]acetico
- [(1R,2R,3aS,9aS)-2-Hydroxy-1-((S)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphthalen-5-yloxy]essigsäure
- Treprostinil
Alternative medicine with selected ingredient
Name | PZN | Form | Packing | Manufacturer | Price | |
---|---|---|---|---|---|---|
Details | TREPULMIX 1 mg/ml Infusionslösung 10mg | P16802150 | INF | 1 St | AOPOG | € 2103.90 |
Details | TREPROSTINIL Tillomed 2,5 mg/ml Infusionslsg.50mg | P17196303 | INF | 1 St | TILLP | € 4911.43 |
Details | TREPROSTINIL betapharm 10 mg/ml Infusionslsg.200mg | P7751086 | INF | 1 St | BETAP | € 19430.32 |
Details | REMODULIN 10 mg/ml 20 ml vial Infusionslsg.200mg | P2328213 | INF | 1 St | OMT | € 22852.00 |
Details | TREPULMIX 2,5 mg/ml Infusionslösung 25mg | P16802144 | INF | 1 St | AOPOG | € 3858.61 |
Details | TREPROSTINIL Tillomed 10 mg/ml Infusionslsg.200mg | P17196332 | INF | 1 St | TILLP | € 15555.41 |
Details | TREPROSTINIL betapharm 1 mg/ml Infusionslsg.20mg | P9098213 | INF | 1 St | BETAP | € 4960.46 |
Details | TREPROSTINIL beta 2,5 mg/ml Infusionslsg.50mg | P14407107 | INF | 1 St | BETAP | € 6124.87 |
Details | TREPROSTINIL Tillomed 1 mg/ml Infusionslsg.20mg | P17196295 | INF | 1 St | TILLP | € 2690.46 |
Details | TREPROSTINIL betapharm 5 mg/ml Infusionslsg.100mg | P7751063 | INF | 1 St | BETAP | € 11640.32 |